Introduction
Vibrio cholerae hemolysin (HlyA) monomer, a pore-forming toxin, upregulates TLR2 and drives the mouse peritoneal cavity (PerC) B-1a cell, an important constituent of mucosal immune system, to apoptosis (1) . In contrast, the HlyA oligomer (2) , though recognized by the same TLR, results in nuclear translocation of NF-κB and induction of IgA. In this paper, we evaluated B-1a cell proliferation, expression of B cell activation marker CD25 (3) , and upregulation of the costimulatory molecules, CD80-CD86, as hallmark of cell activation and prelude to HlyA oligomer-induced IgA response. We further investigated the participation of regulatory chemokines that tilt the balance towards apoptosis or activation in response to this unique dimorphic molecule.
Chemokines display pleiotropic functions in addition to regulation of leukocyte trafficking (4) . For example, CXCL9, CXCL10 and CXCL11 exhibit the ability to recruit different leukocyte subsets, the capacity to induce proliferation as well as powerful anti-tumor effects, which are mediated by a common receptor, CXCR3 (5, 6) . CXCR3, present on activated Th1 cells, is also expressed on a subset of peripheral blood B cells and distinct subtypes of B cell lymphomas (7). CXCR3 and its ligands, by virtue of their ability to regulate both cell proliferation and apoptosis may play a pivotal role in the differential response of B-1a cells to the two forms of HlyA and thus be the factor deciding life or death of the cells.
Materials and Methods

Immunogen
The HlyA monomer and oligomer were purified from a non-O1 V. cholerae strain V 2 as described before (2, 8) .
Animals BALB/c mice were maintained as described before (9) . Experiments were approved by the Animal Ethical Committee of National Institute of Cholera and Enteric Diseases, Kolkata.
Cell culture B cells of six-week-old mice were cultured as described (10) with and without 0.5 μg/well of HlyA monomer or oligomer. Briefly, the cells of the monocyte-macrophage lineage were removed from the peritoneal washing by adhering on Petri dishes for 2 h. The non-adherent peritoneal B cells were collected after removing the erythrocytes. The cells were cultured in 96-well round-bottomed tissue culture plates at 1 × 10 5 cells/well/200 μl in RPMI 1640 (Life Technologies, Inc.) containing 5 U/ml penicillin, 5 μg/ml streptomycin, 0.1% gentamicin, 2% fetal bovine serum and 0.1% insulin-transferrin-selenium at 37°C in 5% CO 2 for 72 h. + cells with high fluorescence intensity (upper right quadrant) in a CD19 versus CD5 plot were gated and analyzed by flow cytometry to evaluate B-1a cell proliferation. The quadrant was set by using isotype control.
PerCP-conjugated anti-mouse CD19 mAb and PEconjugated anti-mouse CD5 mAb stained cells were aliquoted and incubated at 4°C in the dark for 20 min with respective FITC-conjugated anti-mouse mAb to detect CD25, CD80 and CD86. Parallel sets of cells were incubated with monoclonal immunoglobulin isotypes. Fluorescence intensity of these cells served as non-specific negative control. The CXCR3 expression of the CD19 + CD5 + cells was assessed by incubation with polyclonal rabbit anti-mouse CXCR3 Ab (Zymed Laboratories Inc.) and FITC-conjugated anti-rabbit immunoglobulin (BD Biosciences Pharmingen).
Results and Discussion
PerC B-1a cells cultured with HlyA oligomer for 72 h were increased in number by 2.6 fold (2.61 ± 0.17, p < 0.05) over untreated control ( Figure 1A ) indicating that the oligomer is effective in stimulating B-1a cell proliferation. At 0 h, the onset of culture, oligomer-treated cells were merely 1.4 fold (1.38 ± 0.18, p < 0.005) more than the untreated ones. Since cell proliferation and activation goes hand in hand, the oligomer-induced proliferation of B-1a cells hints at its ability to activate the cells.
B cells when activated express CD25, as seen with E. coli heat labile enterotoxin EtxB (3). The oligomer upregulated CD25 expression by 2 fold (1.99 ± 0.28, p < 0.05) while the monomer had no effect on its expression ( Figure 1B) . Moreover, the HlyA oligomer induced the expression of CD86 solely and robustly on B-1a cells, which was 20 fold (20.20 ± 0.75, p < 0.005) higher than control, with CD80 expression remaining unaffected ( Figure 1C ). The HlyA monomer had no effect on the expression of the costimulatory molecules. The data suggest that the oligomeric protein can activate the cells to trigger the mucosal immune response through the selective recruitment of the B7-2 (CD86) member of B7 family (1) .
Host cells when exposed to pathogenic stimuli employ signaling molecules including chemokines to regulate immune response. The messages encrypted in the chemokines is received and decoded by specific receptors leading to various cellular responses. The angiostatic chemokines of the CXC family (11), CXCL4 and the CXCR3 ligands, have been proposed as useful therapeutic agents in cancer (12) due to their ability to promote tumor cell death (4). However, the CXCR3 ligands CXCL9 and CXCL10 can also induce increased survival and growth of mesangial cells through the same receptor (13) . Since the expression of CXCR3 could be traced only on activated murine B cells (14) as opposed to normal and malignant B cells in humans (7), it becomes essential to ascertain its involvement in the HlyA oligomer mediated activation of B-1a cells.
Compared to the untreated cells (1.36 ± 0.03%), 5.96 ± 0.06% of the oligomer-treated cells expressed CXCR3 (p < 0.005), while only 1.76 ± 0.04% of the monomer treated cells expressed CXCR3 (p < 0.05) (Figure 2A) . The differential expression of CXCR3 by HlyA monomer and oligomer shows its involvement in the oligomer-induced proliferation and activation of B-1a cells. CXCR3 ligands can cause either cell proliferation or death depending on the cell type (11) and thereby may play a regulatory role in HlyA-induced apoptosis or activation of B-1a cells. This led us to evaluate the expression of these chemokines in response to the dimorphic protein. The oligomer-treated cells upregulated the expression of CXCR3, but failed to express any of its ligands just like the monomer (data not shown). However, the monomer exclusively induced the expression of CXCL4, which was totally absent in the control ( Figure 2B ). CXCL4 or platelet factor 4 (PF-4) is involved in the control of proliferation of endothelial cells and hematopoietic progenitors (11) . In addition to sharing several activities with the CXCR3 ligands, it also inhibits proliferation of activated human T cells (15) . Moreover, it has been identified as a ligand for CXCR3-B, the apoptosisassociated alternately spliced form of CXCR3 in humans (11) . Therefore, HlyA monomer may trigger the apoptotic events in B-1a cells by utilizing the involvement of CXCL4 in down-regulating proliferation and promoting apoptosis.
Regulated cell proliferation and death are central to lymphocyte development and immune response. Here it is seen that the same host cell when treated with an apoptotic stimulus, not only loses the ability to express the activationassociated chemokine receptor CXCR3, but also expresses a powerful angiostatic chemokine CXCL4, previously not implicated in B cell response. This differential expressions of the chemokine receptor and an angiostatic chemokine related with apoptosis by the two forms of HlyA are in accordance to their previously observed difference in immune regulation (1) . Our study shows that B-1a cells, during interaction with HlyA recruit entirely different regulatory molecules that implement specific attributes of the dimorphic protein by skewing the intricate immune response causing apoptosis by the monomer and activation by the oligomer. 6 B-1a cells were reverse-transcribed by using RETROscript™ kit (Ambion Inc.). cDNA served as template for the amplification of CXCL4 (forward: 5'-AGA AAG CGA TGG AGA TCT TAG C-3'; reverse: 5'-CTA ACT CTC CAG GAT TTT CTT G-3') and GAPDH (forward: 5'-CCA TGG AGA AGG CTG GGG-3'; reverse: 5'-CAA AGT TGT CAT GGA TGA CC-3') transcripts by PCR in an automated thermal cycler using SuperTaq™ polymerase. Ethidium bromide-stained PCR products were photographed, their images digitized and analyzed using UVP Labwork software of the gel documentation system (UVP, Upland, CA). The data shown are representative of three independent experiments.
